Sabril (vigabatrin) oral solution recalled for cross-contamination
Lundbeck LLC recalls Sabril (vigabatrin) oral solution nationwide due to potential cross-contamination. The recall affects 10,543 cartons.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall, which typically indicates lower risk. The recall concerns potential cross-contamination with unspecified products, and no illnesses or injuries have been reported. This classification fits the 'precautionary recalls' category.
Plain-English summary
Lundbeck LLC is recalling Sabril (vigabatrin) 500 mg oral solution nationwide due to potential cross-contamination with other products. The recall affects 10,543 cartons.
The affected product is manufactured by Patheon in Cincinnati, Ohio (NDC 67386-211-65). The following lot numbers are included in the recall: Lots 3207333A and 3207334A (Exp. 03/2027), and Lots 3214707A, 3214709A, and 3214710A (Exp. 02/2028).
Vigabatrin is a prescription medication used to treat seizures.
The recalled product
- Product
- SABRIL (VIGABATRIN)
- Brand
- SABRIL
- Manufacturer
- Lundbeck LLC
- Category
- Drug
- Hazard
- Affected units
- 10,543
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot#: 3207333A
- 3207334A
- Exp 03/2027
- 3214707A
- 3214709A
- 3214710A
- Exp 02/2028 .
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · cross contamination
See all →- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
- ModeratePrimidone tablets recalled over potential acemetacin cross-contamination at API manufacturer
FDA (Drugs) · 2026-06-17
- HighFly By Jing creamy sesame noodles may contain undeclared peanut
FDA (Food) · 2026-06-03
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets 50 mg Recalled for API Cross-Contamination
FDA (Drugs) · 2026-05-27